ABRI

ABRI is a biotechnology startup that has been operating since 2007. The company positions itself as an independent and neutral source of bio-products, catering to the needs of its customers by offering a collection of rare, highly characterized biological samples. ABRI prides itself on its ability to consistently deliver high-quality samples in a timely and efficient manner, all while ensuring full regulatory compliance. With a keen understanding of the regulatory environment and strong project management capacities, ABRI enables the commercialization of regulated products, making it a valuable partner for companies involved in time-sensitive product development. Its customers rely on ABRI to expedite their time to market, highlighting the company's importance in the biotechnology industry.